We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of COEPW yet.

COEPW Hedge Fund Activity: Q1 2026 in Review

10 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2026, worth a combined $6.28K — up 35% from $4.63K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of COEPW and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Meteora Capital, opening a new position worth an estimated $1.38K. The largest seller was Landscape Capital Management, exiting entirely with an estimated $346 sold.

  • 10 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2026, down from 11 in Q4 2025.
  • Funds reported $6.28K of Coeptis Therapeutics Warrants stock for Q1 2026, up 35% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2026 and 3 closed out, a net change of -1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q1 2026 was Meteora Capital, an estimated $1.38K added.
  • The largest Coeptis Therapeutics Warrants seller in Q1 2026 was Landscape Capital Management, an estimated $346 sold.

Based on aggregated 13F filings for Q1 2026.